Radiation Oncologist Makes Case for Radiotherapy for Local Treatment of Select Patients

EGFR Resisters Announce 5th Annual Research Summit

In Brief for May 24, 2023

ADAURA Demonstrates OS Benefit with Adjuvant Osimertinib in Resectable EGFRm NSCLC

Data Supporting IO Before Surgery in Resectable NSCLC Grows

Majority of NSCLC Patients from Low Socio-Economic Areas in England Do Not Receive Novel Anti-Cancer Therapies

From the Editors: Defining Resectability of Non-Small Cell Lung Cancer in 2023

Tumor Treating Fields May Provide Additional Treatment Option for mNSCLC Following Progression

Artificial Intelligence in Healthcare: A Patient Perspective

Adding Pembrolizumab to Platinum and Pemetrexed Improves OS in Treatment-Naive MPM

Exploratory IMpower010 Analysis Shows Surgery Type Associated with Favorable DFS, OS Results

In Brief for July 26, 2023